INDEPTH Network
  • Contact Us
  • Login
  • Logo
    • Home
    • What is this?
    • How to use it?
    • History
    • Data
    • Citations
    • News
    • INDEPTHStats
    • Acknowledgements
    • Feedback


    South Africa - Treatment eligibility and retention in clinical HIV care: a regression-discontinuity study in South Africa. PLOS Medicine 2017

    PLOS_Medicine
    Reference ID Bor.PLoSMed.2017.Replication.Data
    Year 2011 - 2012
    Country South Africa
    Producer(s) Bor J*
    Fox MP
    Rosen S
    Venkataramani A
    Tanser F
    Pillay D
    Bärnighausen T
    Collection(s)
    PLOS Medicine
    Metadata PDF Documentation in PDF
    Created on
    Nov 09, 2017
    Last modified
    Nov 13, 2017
    Page views
    62690
    • Study Description
    • Data Dictionary
    • Get Microdata
    • Overview
    • Sampling
    • Data Collection
    • Access policy
    • Export Metadata
    Overview
    Identification
    Country
    South Africa
    Title
    Treatment eligibility and retention in clinical HIV care: a regression-discontinuity study in South Africa. PLOS Medicine 2017

    Study Type
    Health System
    Series Information
    We included data on all routine clinic visits and routine CD4 and viral load test dates from 12 August 2011 through through 31 December 2013.

    ID Number
    Bor.PLoSMed.2017.Replication.Data
    Version
    Version Description
    V1: Edited dataset for public distribution.

    Overview
    Abstract
    This paper examined the effect of immediate (vs. deferred) ART on retention in care using a regression discontinuity design.

    The analysis included all patients (n=11,306) entering clinical HIV care with a first CD4 count between 12 August 2011 and 31 December 2012 in the Hlabisa HIV Treatment and Care Programme. We included data on all routine clinic visits and routine CD4 and viral load test dates from 12 August 2011 through 31 December 2013. During the period of study, patients were assigned to immediate vs. deferred ART eligibility, as determined by a CD4 count <350 cells/µL, per South African national guidelines. Patients referred to pre-ART were instructed to return every 6 months for CD4 monitoring. Patients initiated on ART were instructed to return at 6 and 12 months post-initiation and annually thereafter for CD4 and viral load monitoring. We assessed retention in HIV care at 12 months, as measured by the presence of a clinic visit, lab test, or ART initiation 6 to 18 months after initial CD4 test. Differences in retention between patients presenting just above vs just below the 350-cell threshold were estimated using local linear regression models with a data-driven bandwidth, and the algorithm for selecting the bandwidth chosen ex ante. Further details on study methods are available in the published work.

    The replication dataset provided here is the analytical dataset for the study. It is a de-identified dataset with only the variables necessary to replicate the analysis. (To preserve confidentiality, we report ages in 5-yr intervals, dates in quarters, and mask the clinic names.) The replication data were constructed from raw data files from the ARTemis database on the Hlabisa HIV Treatment and Care Programme. Information on the Hlabisa HIV Treatment and Care Programme and ARTemis can be found in the Cohort Profile published as Houlihan et al. (2011) Int J Epidemiology. The raw data are available through request to the Africa Health Research Institute (www.ahri.org ).

    Kind of Data
    Biomeasures data

    Units of Analysis
    Individual

    Scope
    Notes
    The analysis included all patients (n=11,306) entering clinical HIV care with a first CD4 count between 12 August 2011 and 31 December 2012 in the Hlabisa HIV Treatment and Care Programme. We included data on all routine clinic visits and routine CD4 and viral load test dates from 12 August 2011 through 31 December 2013.

    We included data on all routine clinic visits and routine CD4 and viral load test dates from 12 August 2011 through through 31 December 2013.

    Topics
    TopicVocabularyURI
    HIV [D006678] MeSHhttp://www.ncbi.nlm.nih.gov/mesh
    Keywords
    Clinical HIV care, CD4, ART (Antiretroviral Therapy)
    Coverage
    Geographic Coverage
    The geographic coverage is Hlabisa, which is a settlement in Umkhanyakude District Municipality in the KwaZulu-Natal province of South Africa. The village lies between the Hluhluwe and Umfolozi game reserves, some 40 km north-west of Mtubatuba. Named after the Hlabisa tribe of Zulus.

    Universe
    All patients (n=11,306) entering clinical HIV care with a first CD4 count between 12 August 2011 and 31 December 2012 in the Hlabisa HIV Treatment and Care Programme.

    Producers and Sponsors
    Primary Investigator(s)
    NameAffiliation
    Bor J*
    Fox MP
    Rosen S
    Venkataramani A
    Tanser F
    Pillay D
    Bärnighausen T
    Other Acknowledgements
    NameAffiliationRole
    All patients in the Hlabisa HIV Treatment and Care Programme
    Metadata Production
    Metadata Produced By
    NameAbbreviationAffiliationRole
    Sweetness H. DubeAfrica Helth Research Institure (AHRI)DDI Author
    Date of Metadata Production
    2017-11-08
    DDI Document Version
    V1

    DDI Document ID
    DDI.Bor.PLoSMed.2017.Replication.Data

      Logo
    Logo

    ©2013 INDEPTH Network, All Rights Reserved